Molecular Formula | C14H10O2S |
Molar Mass | 242.29 |
Density | 1.383 |
Melting Point | 295 °C(dec.) |
Boling Point | 477.0±30.0 °C(Predicted) |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Appearance | Solid |
Color | Pale Grey |
pKa | 9.32±0.15(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 4.127 ml | 20.636 ml | 41.273 ml |
5 mM | 0.825 ml | 4.127 ml | 8.255 ml |
10 mM | 0.413 ml | 2.064 ml | 4.127 ml |
5 mM | 0.083 ml | 0.413 ml | 0.825 ml |
biological activity | eprogen receptor modulator 1 (compound 18) is an orally active selective eprogen receptor modulator (SERM), the pIC50 value was 0.46. Eprogen receptor modulator 1 has potential anti-tumor activity. |
Target | Value |
ER (Cell-free assay) | 0.46(pIC50) |
Cell Line: | T47D:A18/PKCα and T47D:A18-TAM1 cells MCF-7:5C cells |
Concentration: | 100 nM 100 nM |
Incubation Time: | 10 days 9 days |
Result: | Inhibit T47D:A18/PKCα and T47D:A18-TAM1 colony formation. Significantly inhibited the growth of MCF-7:5C cells. Significantly reduced tumor volume. |
Animal Model: | 4-6 week old athymic mice (Harlan-Sprague-Dawley) |
Dosage: | 1.5 mg/animal |
Administration: | p.o. ; daily for 2 weeks |